Scholarlink

Background <p>The use of natural health products (NHP) is constantly increasing worldwide. Among the most NHP consumed in the Arabian Peninsula are the resins of <i>Commiphora myrrha</i> (<i>C. myrrha</i>) tree. Consumption of <i>C. myrrha</i> may result in herb-drug interactions mediated by drug-metabolizing cytochrome P-450 (CYP) enzymes in the liver, which could lead to serious health consequences for patients. This study aims to determine the herb-drug interactions based on the induction of predominant CYP 2C9 by a non-toxic boiled aqueous extract of <i>C. myrrha</i> and to unveil the potential involvement of xenobiotic-sensing nuclear receptors such as transcription factor Pregnane X Receptor (PXR) in CYP 2C9 induction, and to predict the molecular interactions of PXR with <i>C. myrrha</i>-derived metabolite(s).</p> Methods <p>Cytotoxic effect of boiled aqueous extract of <i>C. myrrha</i> resins in cultured liver carcinoma Hep G2 cells was assessed using MTT assay. CYP 2C9 gene and protein expression levels were evaluated using reverse transcription-quantitative polymerase chain reaction and Western blot. Nuclear receptor binding assays, chemical analysis and molecular docking prediction were performed using specific kits, liquid chromatography-mass spectrometry time-of-flight, and in silico software, respectively.</p> Results <p>Tested at low concentrations (0.01–10&#xa0;µg/mL) devoid of anti-proliferative effects, boiled <i>C. myrrha</i> resin aqueous extract upregulated CYP 2C9 gene and protein expressions in a dose-dependent manner, reaching a mean expression level exceeding 3.0-fold change in Hep G2 cells, compared with the basal level expressed in untreated cells. Furthermore, the use of the nuclear receptor binding assays confirmed the binding between <i>C. myrrha</i> metabolite(s) and PXR, while no binding to the other xenobiotic-sensing nuclear receptor, the constitutive androstane receptor (CAR), was observed. Chemical analysis and computational molecular docking using in silico studies revealed that a few <i>C. myrrha</i> resin-derived metabolites are strongly bound to PXR. In particular, the identified metabolite named commic acid E exhibited a predicted molecular docking score close to that of a native PXR ligand, suggesting <i>C. myrrha</i> metabolite(s) as potential PXR agonists.</p> Conclusions <p>Although in vivo studies are needed, this study cautions patients, healthcare providers, and governmental regulators against the consumption of <i>C. myrrha</i> preparations with a high potential for herb-drug interactions through drug-metabolizing CYP 2C9 enzyme induction, which could affect drug efficacy.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Commiphora myrrha resin extract-modulated cytochrome P-450 2C9 enzyme expression in cultured Hep G2 cells is associated with resin extract-derived metabolites binding to Pregnane X receptor

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年7月9日

查看全文
  • Amani Alsharidah,
  • Zeyad Alehaideb,
  • Sahar S. Alghamdi,
  • Rasha S. Suliman,
  • Saleh Althenayyan,
  • Feras Almourfi,
  • Bader Hazazi,
  • Aljawharah Almogren,
  • Abeer Al Tuwaijri,
  • Mohamed Boudjelal,
  • Afrah Alkhuriji,
  • Sabine Matou-Nasri

摘要

Background

The use of natural health products (NHP) is constantly increasing worldwide. Among the most NHP consumed in the Arabian Peninsula are the resins of Commiphora myrrha (C. myrrha) tree. Consumption of C. myrrha may result in herb-drug interactions mediated by drug-metabolizing cytochrome P-450 (CYP) enzymes in the liver, which could lead to serious health consequences for patients. This study aims to determine the herb-drug interactions based on the induction of predominant CYP 2C9 by a non-toxic boiled aqueous extract of C. myrrha and to unveil the potential involvement of xenobiotic-sensing nuclear receptors such as transcription factor Pregnane X Receptor (PXR) in CYP 2C9 induction, and to predict the molecular interactions of PXR with C. myrrha-derived metabolite(s).

Methods

Cytotoxic effect of boiled aqueous extract of C. myrrha resins in cultured liver carcinoma Hep G2 cells was assessed using MTT assay. CYP 2C9 gene and protein expression levels were evaluated using reverse transcription-quantitative polymerase chain reaction and Western blot. Nuclear receptor binding assays, chemical analysis and molecular docking prediction were performed using specific kits, liquid chromatography-mass spectrometry time-of-flight, and in silico software, respectively.

Results

Tested at low concentrations (0.01–10 µg/mL) devoid of anti-proliferative effects, boiled C. myrrha resin aqueous extract upregulated CYP 2C9 gene and protein expressions in a dose-dependent manner, reaching a mean expression level exceeding 3.0-fold change in Hep G2 cells, compared with the basal level expressed in untreated cells. Furthermore, the use of the nuclear receptor binding assays confirmed the binding between C. myrrha metabolite(s) and PXR, while no binding to the other xenobiotic-sensing nuclear receptor, the constitutive androstane receptor (CAR), was observed. Chemical analysis and computational molecular docking using in silico studies revealed that a few C. myrrha resin-derived metabolites are strongly bound to PXR. In particular, the identified metabolite named commic acid E exhibited a predicted molecular docking score close to that of a native PXR ligand, suggesting C. myrrha metabolite(s) as potential PXR agonists.

Conclusions

Although in vivo studies are needed, this study cautions patients, healthcare providers, and governmental regulators against the consumption of C. myrrha preparations with a high potential for herb-drug interactions through drug-metabolizing CYP 2C9 enzyme induction, which could affect drug efficacy.